Magazine - Pharmacist Digest

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

JULY 10, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Vaccines Immunity Immunization

NHS England secures access to new cystic fibrosis treatment ALYFTREK

Pharma Times

JULY 15, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

UCB reports success in phase 3 study of fenfluramine for CDD

Pharma Times

JUNE 30, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023 This field is required.

Diabetes

Diabetes Labelling

MHRA approves first oral treatment for hereditary angioedema attacks

Pharma Times

JULY 15, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

PharmaShots Magazine-June-2025 Edition

PharmaShots

JUNE 12, 2025

The July Edition of PharmaShots Magazine will revolve around the topic “Unlocking the Future: Insights into Regenerative Medicine” and the August Edition will focus on the Cosmeceutical Industry. Send us your promotional pieces at connect@pharmashots.com The post PharmaShots Magazine-June-2025 Edition appeared first on PharmaShots.

eXmoor and Signadori Bio enter cell therapy partnership

Pharma Times

JUNE 19, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023 This field is required.

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

Pharma Times

JULY 17, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Labelling

BiomX phage therapy shows potent effect in cystic fibrosis trial

Pharma Times

JULY 9, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Communication

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

JUNE 24, 2025

Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Packaging Biosimilars Pharmaceutical Companies

VarmX secures US approval to begin phase 3 trial of urgent surgery treatment

Pharma Times

JULY 8, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

JUNE 26, 2025

Can pharma tariffs “Make America Manufacture Again”?

Compounding

Compounding Drug Development Communication Packaging

Actithera closes $75.5m Series A to advance radioligand therapy platform

Pharma Times

JULY 9, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Actithera closes $75.5m

Moderna flu vaccine shows superior results in phase 3 study

Pharma Times

JULY 1, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Vaccines Adverse Reactions

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies

Vutrisiran marks first silencer approved for ATTR-CM

Pharmaceutical Technology

JUNE 12, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Pharmaceutical Technology

JUNE 10, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Drug Pricing Packaging

Cidara and hVIVO report positive results in flu prevention study

Pharma Times

JUNE 30, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023 This field is required.

Diabetes

Diabetes Vaccines

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

JUNE 13, 2025

Can pharma tariffs “Make America Manufacture Again”?

Vaccines

Vaccines Communication Hospitals Packaging

Neumifil shows promise in treating influenza with positive phase 2 dat

Pharma Times

JULY 2, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

JUNE 23, 2025

Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

Ethris and Thermo Fisher partner on mRNA solutions

Pharmaceutical Technology

JUNE 16, 2025

Can pharma tariffs “Make America Manufacture Again”?

Insurance Coverage and Processing

Insurance Coverage and Processing Vaccines Communication Hospitals

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Packaging Hospitals

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Labelling

Labelling Packaging Communication Hospitals

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

JUNE 19, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

Juvenescence enhances AI drug discovery with Ro5 acquisition

Pharmaceutical Technology

JUNE 6, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Drug Pricing Packaging

EC authorises Sydnexis’ paediatric myopia treatment

Pharmaceutical Technology

JUNE 6, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Drug Pricing Packaging

Orion and Glykos extend ADC collaboration

Pharmaceutical Technology

JUNE 18, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

JUNE 20, 2025

Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

JUNE 9, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Drug Pricing Packaging

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Pharmaceutical Technology

JULY 16, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Communication Hospitals Drug Development

ADA: Vertex closer to weaning type 1 diabetics off insulin

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Drug Development Chemotherapy Biosimilars

Piramal Pharma announces $90m investment to expand US sites

Pharmaceutical Technology

JULY 1, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Communication

Communication Packaging Hospitals Drug Pricing

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

JUNE 25, 2025

Can pharma tariffs “Make America Manufacture Again”?

Packaging

Packaging Communication Hospitals Drug Development

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

Can pharma tariffs “Make America Manufacture Again”?

Vaccines

Vaccines Pharmaceutical Manufacturing Communication Hospitals

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

JUNE 23, 2025

Can pharma tariffs “Make America Manufacture Again”?

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Hospitals

MSD receives FDA approval for Enflonsia to prevent RSV

Pharmaceutical Technology

JUNE 10, 2025

Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Research Laboratories Hospitals Drug Pricing

Government to adopt EU standards for high-risk diagnostic devices

Pharma Times

JULY 10, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

JULY 7, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Communication Hospitals Drug Pricing

FDA gives TSND-201 breakthrough therapy designation for PTSD

Pharmaceutical Technology

JULY 10, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Hospitals Communication Drug Pricing

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

Pharmaceutical Technology

JULY 2, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Packaging

Packaging Communication Hospitals Drug Pricing

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

JULY 11, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Drug Pricing

Drug Pricing Hospitals Medical Records Drug Development

Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer

Pharma Times

JULY 14, 2025

Content News Magazine Advertise Contact Competitions Connect Follow Follow Follow Follow Follow Legal Privacy Policy Terms and Conditions Editorial policy Cookies RSS – feed subscriptions © Copyright PharmaTimes Media Limited 2023

Vaccines

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial (..)

Osivax publishes phase 2a results supporting dual flu vaccine approach

NHS England secures access to new cystic fibrosis treatment ALYFTREK

Trending Sources

UCB reports success in phase 3 study of fenfluramine for CDD

MHRA approves first oral treatment for hereditary angioedema attacks

PharmaShots Magazine-June-2025 Edition

eXmoor and Signadori Bio enter cell therapy partnership

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

BiomX phage therapy shows potent effect in cystic fibrosis trial

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

VarmX secures US approval to begin phase 3 trial of urgent surgery treatment

How AI and machine learning are transforming drug discovery

Actithera closes $75.5m Series A to advance radioligand therapy platform

Moderna flu vaccine shows superior results in phase 3 study

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

Vutrisiran marks first silencer approved for ATTR-CM

Mosanna Therapeutics gains $80m to advance OSA nasal spray

Cidara and hVIVO report positive results in flu prevention study

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Neumifil shows promise in treating influenza with positive phase 2 dat

EC approves argenx’s efgartigimod alfa for CIDP treatment

Ethris and Thermo Fisher partner on mRNA solutions

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

FDA approves label updates for BMS’ CAR T cell therapies

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Juvenescence enhances AI drug discovery with Ro5 acquisition

EC authorises Sydnexis’ paediatric myopia treatment

Orion and Glykos extend ADC collaboration

Madrigal poised to enter European MASH market after CHMP endorsement

The European Market Access Lag: 2021–2024

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

ADA: Vertex closer to weaning type 1 diabetics off insulin

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Piramal Pharma announces $90m investment to expand US sites

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

DoH – Abu Dhabi and Sanofi link for vaccine development

Harbour BioMed partners Otsuka on new T-cell therapy

MSD receives FDA approval for Enflonsia to prevent RSV

Government to adopt EU standards for high-risk diagnostic devices

FDA approves KalVista’s Ekterly for hereditary angioedema

FDA gives TSND-201 breakthrough therapy designation for PTSD

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

The unsustainability of clinical trials and need for transformative change

Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer

Big pharma braces for revenue headwinds as patent expiries loom

Stay Connected